Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Interventional, National Study Of Real-World Evidence In Estrogen Receptor Positive, Her2 Negative Metastatic Breast Cancer Patients Treated With Palbociclib During a 2.5 Years Follow-Up Period

NCT05135104 is registered in ClinicalTrials.gov with Asociatia Oncohelp - Centrul de Oncologie Oncohelp as lead sponsor.

NCT NCT05135104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05135104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Interventional, National Study Of Real-World Evidence In Estrogen Receptor Positive, Her2 Negative Metastatic Breast Cancer Patients Treated With Palbociclib During a 2.5 Years Follow-Up Period
Lead sponsor
Asociatia Oncohelp - Centrul de Oncologie Oncohelp
Phase
Observational
Overall status
Unknown status
Start date
December 15, 2021
Completion date
May 25, 2024
Enrollment
650 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer